Posted by Daniel Bedinger PhD

Erica Ollmann Saphire, PhD, Professor, La Jolla Institute for Immunology

Presentation at the National Institutes of Health (NIH) by the Coronavirus Immunotherapy Consortium (COVIC)

Dr. Erica Ollmann Saphire of the La Jolla Institute for Immunology presents how the Gates-funded COVID-19 consortium has fully characterized 350 therapeutic candidate antibodies from all over the world in record time. The revolutionary Carterra LSA has been integral in identifying the antibodies’ mechanism of action so potential therapies can be pursued and how the best therapeutic cocktail can be developed.